Claveria-Cabello, A. (., Colyn, L. (., Uriarte-Díaz-Varela, I. (., Latasa, M. (. U., Arechederra, M. (., Herranz, J. (. M., . . . García-Fernández-de-Barrena, M. (. (2020). Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis.
Citación estilo ChicagoClaveria-Cabello, A. (Alex)|||/items/ad46f31a-3976-408d-97de-fb1ffe71e6b0, et al. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. 2020.
Cita MLAClaveria-Cabello, A. (Alex)|||/items/ad46f31a-3976-408d-97de-fb1ffe71e6b0, et al. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. 2020.